Altre lingue Duopharma Biotech

Azioni

DPHARMA

MYL7148OO009

Prezzo di chiusura BURSA MALAYSIA Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
1,18 ^MYR	+0,85%		+1,72%	-6,35%

20/03	Duopharma Biotech Berhad annuncia la nomina di Mohd Haris Bin Mohd Arshad a Membro non indipendente e non esecutivo del Comitato di nomina e remunerazione	CI
20/03	Duopharma Biotech Berhad nomina Mohd Haris Bin Mohd Arshad come Direttore non indipendente e non esecutivo	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Duopharma Biotech Clinches MYR578 million Supply Deals	01/05
Duopharma Biotech Berhad Announces the Appointment of Mohd Haris Bin Mohd Arshad as Non Independent and Non Executive Member of Nomination and Remuneration Committee	20/03
Duopharma Biotech Berhad Appoints Mohd Haris Bin Mohd Arshad as Non-Independent and Non-Executive Director	20/03
Duopharma Biotech Berhad Announces the Resignation of Amizar Binti Mizuar as Non Independent and Non Executive Member of Nomination and Remuneration Committee	20/03
Duopharma Biotech Berhad Announces the Resignation of Puan Amizar Binti Mizuar as Non Independent and Non Executive Director	20/03
Duopharma Biotech Berhad Announces the Cessation of Encik Muhammad Shukri Bin Ismail as Non Independent and Non Executive Alternate Director	20/03
Duopharma Biotech's Profit Plummets in Q4 2023	23/02
Duopharma Biotech Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Duopharma Biotech Berhad Announces Second Interim Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 21 March 2024	22/02
Duopharma Biotech Issues Further Islamic Debt Worth MYR29 Million	18/12
Duopharma Biotech Berhad Makes a Further Sukuk Wakalah Issuance of RMB 29.0 Million Under the Sukuk Wakalah Programme	15/12
Duopharma Biotech's Profit Drops in Q3	09/11
Duopharma Biotech Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Duopharma Biotech Bags Supply Deal Extension from Pharmaniga	25/10/23
Duopharma Biotech Berhad Declares Interim Dividend for the 30 June 2023, Payable on 22 September 2023	24/08/23
Duopharma Biotech Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Duopharma Biotech Berhad Appoints ENCIK MUHAMMAD SHUKRI BIN ISMAIL as Non Independent and Non Executive Alternate Director	01/08/23
The Live Green Company announced that it expects to receive $1 million in funding from Duopharma Biotech Berhad	01/08/23
Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award	28/07/23
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market	26/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Duopharma Biotech

Azioni

DPHARMA

MYL7148OO009

Altre lingue

Filtri